全文获取类型
收费全文 | 2043篇 |
免费 | 126篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 51篇 |
妇产科学 | 43篇 |
基础医学 | 359篇 |
口腔科学 | 27篇 |
临床医学 | 179篇 |
内科学 | 496篇 |
皮肤病学 | 63篇 |
神经病学 | 217篇 |
特种医学 | 30篇 |
外科学 | 105篇 |
综合类 | 33篇 |
一般理论 | 1篇 |
预防医学 | 199篇 |
眼科学 | 64篇 |
药学 | 154篇 |
中国医学 | 6篇 |
肿瘤学 | 143篇 |
出版年
2024年 | 6篇 |
2023年 | 22篇 |
2022年 | 65篇 |
2021年 | 105篇 |
2020年 | 58篇 |
2019年 | 81篇 |
2018年 | 81篇 |
2017年 | 47篇 |
2016年 | 67篇 |
2015年 | 80篇 |
2014年 | 114篇 |
2013年 | 127篇 |
2012年 | 173篇 |
2011年 | 164篇 |
2010年 | 94篇 |
2009年 | 62篇 |
2008年 | 136篇 |
2007年 | 121篇 |
2006年 | 122篇 |
2005年 | 97篇 |
2004年 | 75篇 |
2003年 | 87篇 |
2002年 | 80篇 |
2001年 | 14篇 |
2000年 | 9篇 |
1999年 | 2篇 |
1998年 | 5篇 |
1997年 | 8篇 |
1996年 | 8篇 |
1995年 | 11篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 5篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1988年 | 3篇 |
1986年 | 5篇 |
1985年 | 2篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1969年 | 1篇 |
1968年 | 3篇 |
1966年 | 1篇 |
1962年 | 1篇 |
排序方式: 共有2182条查询结果,搜索用时 15 毫秒
101.
Petr Kanovsky Dagmar Kubová Martin Bares Hana Hortová Hana Streitová Ivan Rektor Vladimír Znojil 《Movement disorders》2002,17(1):188-191
Twelve patients with levodopa-induced dyskinesias were treated with continuous subcutaneous apomorphine. A markedly significant reduction in peak dose dyskinesias occurred over a two-year follow-up. 相似文献
102.
An efficient and versatile synthesis of the naturally occurring C-prenylated stilbenoid methyl ethers and their synthetic analogues is presented. The synthesis represents a six step convergent process including an optimised C-prenylation method. Furthermore, during the demethylation process, six new dihydro-benzopyranyl derivatives were obtained and isolated.An efficient and versatile synthesis of the naturally occurring C-prenylated stilbenoid methyl ethers and synthetic analogs has been developed. 相似文献
103.
Kateřina Kamarádová Hana Vošmiková Kateřina Rozkošová Aleš Ryška Ilja Tachecí Jan Laco 《Pathology, research and practice》2019,215(4):730-737
Background
Patients with inflammatory bowel disease (IBD) – ulcerative colitis (UC) and Crohn’s disease (CD) have an elevated risk of developing colorectal carcinoma (CRC). Major risk factor in IBD patients is the continuous chronic inflammation leading to development of dysplasia and carcinoma. Nevertheless, other types of non-conventional but suspicious mucosal changes serrated change/dysplasia, NOS and villous hypermucinous change, have also been reported in IBD patients. Preneoplastic potential of these lesions is still not well elucidated.Aims
The aim of this study was identification of IBD-associated CRCs focusing on finding related precursor lesions in the surgical specimen or in archival biopsy samples followed by a detailed morphological, immunohistochemical and molecular evaluation. For the purpose of the study the mucosal lesions were divided into conventional IBD-associated dysplasia and non-conventional lesions that were merged under a provisory term of putative preneoplastic lesions (PPL).Methods
A total of 309 consecutive IBD colectomy specimens diagnosed during a 10-year period were reviewed. Detailed morphological evaluation, immunohistochemical analysis of mismatch repair (MMR) proteins, p53 and O6-methylguanine DNA methyltransferase (MGMT) expression and molecular analysis for KRAS, NRAS and BRAF gene mutation were performed in the retrieved CRC cases as well as in the detected dysplasia and PPLs of these patients.Results
We identified 11 cases of morphologically heterogenous IBD-associated CRCs, occurring in 5 males and 6 females, aged 26–79 years (mean 44 years). A total of 22 mucosal lesions were revealed in 8 CRC patients comprising conventional IBD-associated dysplasia (4 lesions), PPLs as serrated change/dysplasia NOS (11 lesions), villous hypermucinous change (5 lesions), and two true serrated lesions (one sessile serrated adenoma and one traditional serrated adenoma). More than one type of lesion was found in 6 patients. Seven CRC cases harbored mutation of KRAS/NRAS and one case of BRAF. Two patients with KRAS-mutated CRC showed the same mutation in PPL in the same specimen (one serrated change NOS and one TSA with high-grade dysplasia). Similarly, one BRAF-mutated carcinoma case presented the same mutation in serrated change/dysplasia, NOS in the same specimen. Of the CRCs, two showed deficient MMR system profile, six presented with loss of MGMT expression, and six showed aberrant p53 expression. PPLs showed deficient MGMT expression (14 cases) and aberrant p53 (10 cases) as well.Conclusion
IBD-associated CRCs are very heterogeneous entities. Besides conventional IBD-related dysplasia, other types of mucosal lesions may be associated with long lasting IBD and CRC e.g. villous hypermucinous change and serrated change/dysplasia, NOS. Since these lesions share certain genetic or immunohistochemical changes with the related CRC, a suspicion is raised that these lesions may also have preneoplastic potential. Awareness of these changes is necessary to prevent their missing and under-reporting, and further studies of these lesions should be carried out. 相似文献104.
105.
106.
107.
108.
109.
Bohuslav Melichar Radomír Hyšpler Emanuela Dragounová Josef Dvořák Hana Kalábová Alena Tichá 《BMC cancer》2007,7(1):155
Background
Combination of platinum derivatives with paclitaxel is currently the standard front line regimen for patients with epithelial ovarian carcinoma, and represents also an active regimen in patients with metastatic breast or unknown primary carcinomas. Measurement of intestinal permeability represents one of the potential methods of noninvasive laboratory assessment of gastrointestinal mucositis induced by chemotherapy, but little is known about intestinal permeability in patients treated with paclitaxel or platinum. 相似文献110.
N-Nitroso-N-methylaniline (NMA) is an esophageal carcinogen in the rat. The in vitro enzymatic metabolism of NMA was investigated using cytochromes P450 2B1 and P450 2B2, isolated from liver microsomes of rats pretreated with phenobarbital (PB), reconstituted with NADPH-cytochrome P450 reductase and dilauroylphosphatidylcholine. Formaldehyde is produced by both cytochromes P450 (P450). NMA is a better substrate for P450 2B1 than for P450 2B2. The maximal velocity (Vmax) values are 3.3 and 1.6 nmol HCHO/min per nmol P450 for P450 2B1 and P450 2B2, respectively. Beside formation of formaldehyde, aniline and p-aminophenol (p-AP) are found to be metabolites formed from NMA by both P450 isoenzymes. P450 2B1 also affords phenol, while none was found with the P450 2B2 isoenzyme. Phenol formation presumably arose from direct alpha-C-hydroxylation of NMA via a benzenediazonium ion (BDI) intermediate. The results suggest strongly that P450 2B1 catalyzes both alpha-C-hydroxylation and denitrosation of NMA while P450 2B2 catalyzes only denitrosation. Therefore, the P450 2B1 isoenzyme participates in the activation of NMA to the ultimate carcinogenic BDI. 相似文献